Robert F. Kennedy Jr. proposes expanding access to experimental medical treatments, acknowledging potential risks from unlicensed providers. Is this a step forward or a danger to public health?
Emily Kramer-Golinkoff, a cystic fibrosis patient with a rare mutation, highlights the struggles of those left behind as gene therapies show promise for others. Her journey underscores the need for equitable treatments in rare genetic conditions.
